Global Diabetic Retinopathy Market 2015-2019

1. Top 10 Diabetes Care Technologies, Devices and Therapeutics Markets - Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast 2012 - 2020 Global Diabetic Retinopathy Market 2015-2019

2. Description Report Overview Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision. Analysts forecast the global diabetic retinopathy market to grow at a CAGR of 6.89% over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-diabetic-retinopathy-2015-2019-market @Bigmarketresearch

3. Key Benefits Description The report also presents the vendor landscape and a corresponding detailed analysis of the four major vendors in the market. In addition, it discusses the major drivers that influence the growth and the challenges faced by the vendors and the market at large, as well as the key trends that contribute to the growth the market. Global Diabetic Retinopathy Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global diabetic retinopathy market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Regions • Americas • APAC • EMEA @Bigmarketresearch

4. Description Key Vendors • Bayer • F. Hoffmann-La Roche • Novartis • Regeneron Pharmaceuticals Other Prominent Vendors • Actavis • Alimera Sciences • Ampio Pharmaceuticals • Antisense Therapeutics • BCN Peptides • BoehringerIngelheim • Glycadia @Bigmarketresearch

5. Description • Market Driver • • Growth in patient population • • For a full, detailed list, view our report • Market Challenge • • Availability of effective surgical treatments • • For a full, detailed list, view our report • Market Trend • • Launch of novel agents • • For a full, detailed list, view our report • Enquire About Report @ http://www.bigmarketresearch.com/report-enquiry/226096 @Bigmarketresearch

6. Table Of Contents Table Of Content • 01. Executive Summary • 02. List of Abbreviations • 03. Scope of the Report • 04. Market Research Methodology • 05. Introduction • 06. Disease Overview • 07. Market Landscape • 08. Pipeline Portfolio • 09. Market Segmentation by Type of Molecule • 10. Market Segmentation by Route of Administration • 11. Geographical Segmentation • 12. Buying Criteria • 13. Market Growth Drivers • 14. Drivers and their Impact • 15. Market Challenges • 16. Impact of Drivers and Challenges • 17. Market Trends • 18. Trends and their Impact • 19. Vendor Landscape • 20. Key Vendor Analysis • 21. Other Reports in this Series @Bigmarketresearch

7. Get Full Information At: http://www.bigmarketresearch.com/global-diabetic-retinopathy-2015-2019-market